May Orfali

May Orfali

Keine laufenden Positionen mehr
Health Technology
Commercial Services
Consumer Services

Profil

May Orfali worked as an Executive Director-Global Product Development at Pfizer Inc., Medical Director-Womens Health Group at Boston Scientific Corp., Senior Medical Director-Medical Affairs at Cubist Pharmaceuticals LLC, Principal at Quintiles Transnational Corp., Vice President-Clinical Research & Medical Affairs at Aeris Therapeutics LLC, Chief Medical Officer at PYC Therapeutics Ltd., and Chief Medical Officer at CANbridge Life Sciences Ltd. She also worked as a Principal at the World Health Organization and the United Nations Children's Fund.
Dr. Orfali holds a graduate degree from the University of Cambridge and a doctorate from the University of Baghdad.
She also worked as the President of Rare Disease & Oncology Consulting LLC and as the Chief Medical Officer at Sigilon Therapeutics, Inc. from 2021 to 2023.

Ehemalige bekannte Positionen von May Orfali

UnternehmenPositionEnde
SIGILON THERAPEUTICS, INC. Technik-/Wissenschafts-/F&E-Leiter 10.02.2023
PYC THERAPEUTICS LIMITED Technik-/Wissenschafts-/F&E-Leiter 01.10.2020
PFIZER INC. Corporate Officer/Principal -
Technik-/Wissenschafts-/F&E-Leiter -
Rare Disease & Oncology Consulting LLC
Präsident -
Sehen Sie sich die Erfahrung von May Orfali im Detail an

Ausbildung von May Orfali

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

7

Beziehungen ersten Grades

15

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen15

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Health Technology

Government

Commercial Services

Consumer Services

Health Technology

Health Services

Health Technology

Health Technology

Rare Disease & Oncology Consulting LLC

  1. Börse
  2. Insiders
  3. May Orfali
-40 %: Die besten Tools exklusiv für Abonnenten - Ihr Schlüssel zu den Top-Investitionen der Zukunft!
T
:
:
PROFITIEREN SIE JETZT